Bar-Ad V - Search Results

1

Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma.

Miller R, Song A, Ali A, Niazi M, Bar-Ad V, Martinez N, Glass J, Alnahhas I, Andrews D, Judy K, Evans J, Farrell C, Werner-Wasik M, Chervoneva I, Ly M, Palmer J, Liu H, Shi W. Miller R, et al. Front Oncol. 2022 Apr 29;12:896246. doi: 10.3389/fonc.2022.896246. eCollection 2022. Front Oncol. 2022. PMID: 35574391 Free PMC article.

2

Esophagitis, treatment-related toxicity in non-small cell lung cancer.

Bar-Ad V, Ohri N, Werner-Wasik M. Bar-Ad V, et al. Rev Recent Clin Trials. 2012 Feb;7(1):31-5. doi: 10.2174/157488712799363235. Rev Recent Clin Trials. 2012. PMID: 21864251 Free PMC article. Review.

3

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school.

Zaorsky NG, Malatesta TM, Den RB, Wuthrick E, Ahn PH, Werner-Wasik M, Shi W, Dicker AP, Anne PR, Bar-Ad V, Showalter TN. Zaorsky NG, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e465-9. doi: 10.1016/j.ijrobp.2012.01.058. Int J Radiat Oncol Biol Phys. 2012. PMID: 22704704

4

Bar-Ad V, Leiby B, Witek M, Xiao Y, Cui Y, Dai Y, Cao J, Axelrod R, Campling B, Both S, Werner-Wasik M. Bar-Ad V, et al. Am J Clin Oncol. 2014 Oct;37(5):433-7. doi: 10.1097/COC.0b013e31827de7a2. Am J Clin Oncol. 2014. PMID: 23388558

5

Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study.

Zaorsky NG, Malatesta TM, Showalter TN, Den RB, Shi W, Anne PR, Werner-Wasik M, Dicker AP, Bar-Ad V. Zaorsky NG, et al. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):214-5. doi: 10.1016/j.ijrobp.2013.02.001. Epub 2013 Mar 15. Int J Radiat Oncol Biol Phys. 2013. PMID: 23498775 No abstract available.

6

FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.

Bar-Ad V, Shi W, Tuluc M, Ohri N, Cognetti D, Curry J, Intenso C. Bar-Ad V, et al. J Nucl Med Radiat Ther. 2012 Feb 1;3(1):10.4172/2155-9619.1000124. doi: 10.4172/2155-9619.1000124. J Nucl Med Radiat Ther. 2012. PMID: 24179702 Free PMC article.

7

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.

Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP. Shi W, et al. J Neurooncol. 2014 Jun;118(2):313-319. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13. J Neurooncol. 2014. PMID: 24728831 Clinical Trial.

8

Current management of locally advanced head and neck cancer: the combination of chemotherapy with locoregional treatments.

Bar-Ad V, Palmer J, Yang H, Cognetti D, Curry J, Luginbuhl A, Tuluc M, Campling B, Axelrod R. Bar-Ad V, et al. Semin Oncol. 2014 Dec;41(6):798-806. doi: 10.1053/j.seminoncol.2014.09.018. Epub 2014 Oct 7. Semin Oncol. 2014. PMID: 25499638 Review.

9

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W. Palmer JD, et al. J Neurooncol. 2015 Sep;124(2):215-21. doi: 10.1007/s11060-015-1825-y. Epub 2015 May 30. J Neurooncol. 2015. PMID: 26024653

10

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.

Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR. Shi W, et al. J Neurooncol. 2016 May;127(3):535-9. doi: 10.1007/s11060-016-2059-3. Epub 2016 Jan 29. J Neurooncol. 2016. PMID: 26821711 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page